Tags |
|
|
Links |
|
|
Digg It - Global Acquisitions - The Unsuccessful Factor
When a global company tries to grow in size, only organic growth is not sufficient to help it reach scale. It has to take the path of inorganic growth a
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
lso to keep ahead of competition. This article will elaborate on the critical factors of growth and why corporations fail to pull out successful acquisi
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
tions. Let us start with an example and try to take a step by step approach to see some of the critical factors of global acquisitions. Quaker Oats acqu
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ired Snapple, a soft drink manufacturer, for $1.7 billion in 1994 and then sold it to $300 million in 1997.
Indecisive integration and a clash of manag
Indecisive integration and a clash of manag
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ement styles were reported. What caused a professional company like Quaker Oats to come out unsuccessful in this acquisition. Value destruction is attri
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
buted as one of the major reasons why this acquisition failed. Generally when an acquisition takes place the strategy is drawn in the comfortble boardro
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
oms of the corporate world without considering many real time factors.
The major focus of these strategies are how much revenue can be generated for th
The major focus of these strategies are how much revenue can be generated for th
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
e parent company and how much growth can be achieved. The factors which may skip these discussions or are given less stress is the human factor. One of
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
the most critical factor of a global acquisition is the human factor. When two companies from different countries and different business dynamics merge
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
it makes it very critical to bring the employees and management on the same plane.
It is imperative that a successful acquisition is followed up by a s
It is imperative that a successful acquisition is followed up by a s
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
uccessful implementation. The managers who implement the strategies are rarely at the board meetings that happen before the acquisition. They may also l
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ack knowledge of implementing strategies and in these scenarios the implementation can be seriously handicapped. In the 20th century management research
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ers have put these corporate boardroom decisions under scanner and tried to get an answer to unsuccessful acquisitions.
As mentioned the human factor i
As mentioned the human factor i
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
s all bringing about two different groups of people with different mindsets from two different firms and integrating them. Their goals, objective and as
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
pirations all need to be taken care of in an effective manner with sincerity. The new management needs to take a great deal of responsibility and commun
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
icate to the employees that the acquisition has been done in the broader interest of the two companies and everyone will benefit from it.
Acquisition p
Acquisition p
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
erformance is measured by four different factors. Some of the factors are financial measures, Economic measures, Strategic measures, Executive measures
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
and Strategic measures. We will discuss about all these topics in our next set of articles. For now let us understand that if our acquisition in failing
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
in any of these measures we need to pull up socks and take stock of the situation. You never know, tomorrow may be too late and we would lose the edge
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
that we have today. There is a silver lining to every dark night. A well thought out acquisition can give your company the results that you were looking
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/20552/diggit-Global-Acquisitions--The-Unsuccessful-Factor.html">Global Acquisitions - The Unsuccessful Factor</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/20552/diggit-Global-Acquisitions--The-Unsuccessful-Factor.html]Global Acquisitions - The Unsuccessful Factor[/url]
Related Articles:
Bookmark it:
|